Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GlobeNewswire
*Ad Hoc Announcement Pursuant to Art. 53 LR**Geneva, Switzerland, April 29, 2024 - *Addex Therapeutics (SIX and Nasdaq: ADXN), a..
Center for Drug Evaluation and Research
News and Video Search Results
News coverage
-
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
GlobeNewswire
-
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
GlobeNewswire
-
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
GlobeNewswire
-
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
PR Newswire Asia
- More about:
Food and Drug Administration- Pfizer
0 shares
1 views
You might like
Center for Drug Evaluation and Research media coverage
FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops
Wibbitz Top Stories
FDA Warns Companies to, Stop Selling Potentially Dangerous, , Unapproved Eye Drops.
Gizmodo reports that the United States..
FDA Approves Over-the-Counter Birth Control
Wibbitz Top Stories
FDA Limits Johnson & Johnson’s COVID-19 Vaccine Emergency Use Authorization
Wibbitz Top Stories
Advertisement
More coverage
FAUCI'S CRIMINAL COVID BOMBSHELL - 6090
Rumble
Where has Dr. Fauci gone? All of a sudden the fame-addicted Vaccine Dictator has disappeared. Could it have something to do with..
FDA Postpones Meeting With Expert Advisers on Pfizer’s Vaccine for Young Kids
Wibbitz Top Stories
Pfizer's Antiviral COVID-19 Pill Authorized by FDA
Wibbitz Top Stories
FDA Approves First Injectable HIV PrEP Drug
Wibbitz Top Stories